Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Drug Discovery & Development|September 2, 2004
The race to an orally active Factor Xa inhibitor: recent advancesMimi L Quan, Joanne M Smallheer
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2010
Inhibition of factor XIa as a new approach to anticoagulationWilliam A Schumacher, Joseph M Luettgen, Mimi L Quan, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2023
Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitorsZilun Hu, Doree Sitkoff, Peter W Glunz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2020
Identification of 5H-chromeno[3,4-c]pyridine and 6H-isochromeno[3,4-c]pyridine derivatives as potent and selective dual ROCK inhibitorsZilun Hu, Cailan Wang, Doree Sitkoff, et al.
Journal of Medicinal Chemistry|May 19, 2018
Factor XIa Inhibitors as New AnticoagulantsMimi L Quan, Donald J P Pinto, Joanne M Smallheer, et al.
Bioorganic & Medicinal Chemistry Letters|January 26, 2006
Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitorsMimi L Quan, Qi Han, John M Fevig, et al.
Journal of Thrombosis and Thrombolysis|August 8, 2015
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIaPancras C Wong, Mimi L Quan, Carol A Watson, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Macrocyclic factor XIa inhibitorsCailan Wang, James R Corte, Karen A Rossi, et al.
Pageof 3